نتایج جستجو برای: eso

تعداد نتایج: 3679  

2012
Jin-Ping Lai Avi Z. Rosenberg Markku M. Miettinen Chyi-Chia R. Lee

NY-ESO-1 (CTAG 1B) is highly expressed in the majority of synovial sarcomas and myxoid/round cell liposarcomas as well as in a subset of melanomas, but only rarely in other mesenchymal tumors. This points to a potential for using NY-ESO-1 in the differential diagnosis of these lesions. Furthermore, promising results have been obtained in clinical trials testing NY-ESO-1-targeted immunotherapy i...

Journal: :Blood 2007
Djordje Atanackovic Julia Arfsten Yanran Cao Sacha Gnjatic Frank Schnieders Katrin Bartels Georgia Schilling Christiane Faltz Christine Wolschke Judith Dierlamm Gerd Ritter Thomas Eiermann Dieter Kurt Hossfeld Axel R Zander Achim A Jungbluth Lloyd J Old Carsten Bokemeyer Nicolaus Kröger

Immunotherapies using cancer-testis (CT) antigens as targets represent a potentially useful treatment in patients with multiple myeloma (MM) who commonly show recurrent disease following chemotherapy. We analyzed the expression of 11 CT antigens in bone marrow samples from patients with MM (n=55) and healthy donors (n=32) using reverse transcriptase-polymerase chain reaction (RT-PCR). CT antige...

پایان نامه :وزارت علوم، تحقیقات و فناوری - دانشگاه فردوسی مشهد - دانشکده مهندسی 1391

در این پژوهش روش sa برای بیشینه سازی سختی سازه های دو بعدی مورد استفاده قرار گرفته است. سه مثال در این پایان نامه مطرح شده که عبارتند از صفحه مربعی، صفحه مستطیل شکل و تیر با تکیه گاه ساده (mbb). هدف از این پژوهش تحلیل مسایل با روش بهینه سازی تبرید تدریجی (sa) و بررسی معایب و مزایای آن نسبت به سایر روش های بهینه سازی که توسط پژوهشگران قبلی انجام شده است می باشد. بهینه سازی صفحه مربعی توسط ابوالب...

Journal: :International journal of clinical and experimental pathology 2015
Chunxia Su Ying Xu Xuefei Li Shengxiang Ren Chao Zhao Likun Hou Zhiwei Ye Caicun Zhou

CD133 and cancer-testis antigens (CTAs) may be potential predicted markers of adjuvant chemotherapy or immune therapy, and they may be the independent prognostic factor of NSCLC. Nowadays, there is still no predictive biomarker identified for the use of adjuvant chemotherapy in non-small cell lung cancer (NSCLC) patients. To clarify the role of CD133 and CTAs as a predictive marker for adjuvant...

2006
G. F. Gilmore

We present the results of photometric measurements from images of the LMC cluster ESO 121-SC03 taken with the Advanced Camera for Surveys on the Hubble Space Telescope. Our resulting colour-magnitude diagram (CMD) reaches 3 magnitudes below the main-sequence turn-off, and represents by far the deepest observation of this cluster to date. We also present similar photometry from ACS imaging of th...

Journal: :Genetics 2000
E M Stone C Reifsnyder M McVey B Gazo L Pillus

Silent information regulators, or Sir proteins, play distinct roles in chromatin-mediated transcriptional control at the silent mating-type loci, telomeres, and within the rDNA repeats of Saccharomyces cerevisiae. An unusual collection of sir3 mutant alleles was identified in a genetic screen for enhancers of the sir1 mutant mating-defective phenotype. These sir3-eso mutants, like the sir1 muta...

Journal: :Pathology, research and practice 2010
Alma Demirović Tihana Džombeta Davor Tomas Borislav Spajić Ivana Pavić Tvrtko Hudolin Milan Milošević Hrvoje Cupić Božo Krušlin

The distinction between renal oncocytoma (RO) and chromophobe renal cell carcinoma (ChRCC), especially the eosinophilic variant, can often be difficult. Our study has documented for the first time the expression of MAGE-A3/4 and NY-ESO-1 cancer testis antigens (CTAs) in these tumors. A total of 35 patients (17 ROs and 18 ChRCCs) were included in the study. Two antibodies were used for immunohis...

2012
Lisa M. Ebert Sarah E. MacRaild Damien Zanker Ian D. Davis Jonathan Cebon Weisan Chen

Cancer vaccines are designed to expand tumor antigen-specific T cells with effector function. However, they may also inadvertently expand regulatory T cells (Treg), which could seriously hamper clinical efficacy. To address this possibility, we developed a novel assay to detect antigen-specific Treg based on down-regulation of surface CD3 following TCR engagement, and used this approach to scre...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2002
Yasuhiro Nagata Satoru Ono Mitsutoshi Matsuo Sacha Gnjatic Danila Valmori Gerd Ritter Wendy Garrett Lloyd J Old Ira Mellman

Dendritic cells (DCs) play a critical role in initiating antigen-specific immune responses, because they are able to capture exogenous antigens for presentation to naive T cells on both MHC class I and II molecules. As such, DCs represent important elements in the development of vaccine therapy for cancer. Although DCs are known to present antigens from phagocytosed tumor cells or preprocessed ...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2004
Qiyuan Chen Heather Jackson Phillip Parente Tina Luke Mark Rizkalla Tsin Yee Tai He-Cheng Zhu Nicole A Mifsud Nektaria Dimopoulos Kelly-Anne Masterman Wendie Hopkins Heather Goldie Eugene Maraskovsky Simon Green Lena Miloradovic James McCluskey Lloyd J Old Ian D Davis Jonathan Cebon Weisan Chen

There is increasing evidence showing the involvement of CD4(+) T cells in initiating and maintaining antitumor immune responses. NY-ESO-1 is expressed by various tumors but not normal tissues except testis. We conducted a cancer clinical trial by using full-length NY-ESO-1 protein formulated with ISCOMATRIX adjuvant and injected into patients intramuscularly. Autologous dendritic cells pulsed w...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید